FDA Patient Feedback Meetings: External Model Ramping Up In 2017
• By Paige Monborne
US agency has started transitioning to a new model for Patient-Focused Drug Development meetings, with agency officials attending four externally hosted meetings so far, with at least three more planned for the next few months. So far, the Neurology Products Division has been particularly active with the external meetings.
The US FDA’s Neurology Products Division is taking a lead role in the first wave of externally organized patient input meetings as the agency transitions to a new model to succeed the first wave of FDA-organized and hosted events.
There have been four official meetings under the external model so far, as tracked by FDA based on meetings convened following agency guidelines released in December 2015. A...
